Matthew P. Elliott

Neurology

1215 Lee St
Charlottesville, VA 22908

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6 publications

CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

Journal: JAMA

Published: March 11, 2025

Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

Journal: JAMA

Published: March 11, 2025

Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.

Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.

Journal: JAMA network open

Published: February 17, 2025

Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.

Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.

Journal: JAMA neurology

Published: August 28, 2024

Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Journal: The Lancet. Neurology

Published: November 22, 2023

Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.

Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.

Journal: Neurology

Published: December 22, 2017

Showing 1-6 of 6

Last Updated: 09/26/2026